These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status.
    Author: Aubrey C, Saad N, Köbel M, Mattatall F, Nelson G, Glaze S.
    Journal: Gynecol Oncol; 2021 May; 161(2):342-346. PubMed ID: 33663874.
    Abstract:
    A 36-year-old transgender man (assigned female at birth) on exogenous testosterone therapy was found to have stage IIA ovarian endometrioid carcinoma, and underwent adjuvant chemotherapy. Diffuse androgen receptor expression in the tumor initiated a multidisciplinary discussion regarding the safety of continuing exogenous testosterone as gender-affirming hormone therapy.
    [Abstract] [Full Text] [Related] [New Search]